Sentry Investment Management LLC Charles River Laboratories International, Inc. Transaction History
Sentry Investment Management LLC
- $147 Million
- Q1 2025
A detailed history of Sentry Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Sentry Investment Management LLC holds 146 shares of CRL stock, worth $19,892. This represents 0.01% of its overall portfolio holdings.
Number of Shares
146
Previous 190
23.16%
Holding current value
$19,892
Previous $35,000
42.86%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CRL
# of Institutions
649Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$832 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$693 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$584 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$326 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$266 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.93B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...